Abstract:Ethnopharmacological relevance Epimedium brevicornu Maxim. is a traditional medicinal Chinese herb that is enriched with flavonoids , which have remarkably high medicinal value. Icariin (ICA) is a marker compound isolated from the total flavonoids of Epimedium brevicornu Maxim. It has been shown to improve Neurodegenerative disease, therefore, ICA is probably a potential drug for treating AD. Materials and methods The 6–8-week-old SPF-class male ICR mice were randomly divided into 8 groups for modeling, and then the mice were administered orally with ICA for 21 days. The behavioral experiments were conducted to evaluate if learning and memory behavior were absent in mice, confirming that infusion of Amyloid β-protein (Aβ) 1-42 caused significant memory impairment. The morphological changes and damage of neurons in the mice's brains were observed by HE and Nissl staining. The spinous protrusions (dendritic spines) on neuronal dendrites were investigated by Golgi-Cox staining. The molecular mechanism of ICA was examined by Western Blot. The protein docking of ICA and Donepezil with BDNF were analyzed to determine their interaction. Results The behavioral experimental results showed that in Aβ 1-42 -induced AD mice, the learning and memory abilities were improved after using ICA. At the same time, the low, medium, and high doses of ICA could reduce the content of Aβ 1-42 in the hippocampus of AD mice, repair neuronal damage, enhance synaptic plasticity, as well as increase the expression of BDNF, TrκB, CREB, Akt, GAP43, PSD95, and SYN proteins in the hippocampus of mice. However, the effect with high doses of ICA is more pronounced. The high-dose administration of ICA has the best therapeutic effect on AD mice. After administering the inhibitor k252a, the therapeutic effect of ICA was reversed. The macromolecular docking results of ICA and BDNF protein demonstrated a strong interaction of −7.8 kcal/mol, which indicates that ICA plays a therapeutic role in AD mice by regulating the BDNF-TrκB signaling pathway. Conclusions The results confirm that ICA can repair neuronal damage, enhance synaptic plasticity, as well as ultimately improve learning and memory impairment through the regulation of the BDNF-TrκB signaling pathway.

Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice.

Icariin Ameliorates Learning And Memory Function Via Improving Cerebral Glucose Metabolism Disorder In App/Ps1/Tau Triple Transgenic Alzheimer'S Disease Mice

Immunoregulation of Icariin Combined with Panax Notoginseng Saponins in Mice

Icariin improves learning and memory function in Aβ 1-42 -induced AD mice through regulation of the BDNF-TrκB signaling pathway

Icariin, a Major Constituent of Flavonoids from Epimedium Brevicornum, Protects Against Cognitive Deficits Induced by Chronic Brain Hypoperfusion Via Its Anti-Amyloidogenic Effect in Rats

Icariin Isolated from Epimedium Brevicornum Maxim Attenuates Learning and Memory Deficits Induced by D-Galactose in Rats

Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease

Study on the Ameliorative Effect of Icariin Mediating NO/cGMP/PKGI Signalling Pathway in Alzheimer's Disease.

Anti-Alzheimers molecular mechanism of icariin: Insights from gut microbiota and metabolome combined network pharmacology

Icariin, a Major Constituent from Epimedium Brevicornum, Attenuates Ibotenic Acid-Induced Excitotoxicity in Rat Hippocampus.

Icariin Inhibits Beta-Amyloid Peptide Segment 25-35 Induced Expression of Beta-Secretase in Rat Hippocampus

Icariin Improves Cognitive Deficits and Activates Quiescent Neural Stem Cells in Aging Rats

Icariin Attenuates Beta-Amyloid-Induced Neurotoxicity By Inhibition Of Tau Protein Hyperphosphorylation In Pc12 Cells

Icariin, A Phoshphodiesterase-5 Inhibitor, Improves Learning and Memory in App/Ps1 Transgenic Mice by Stimulation of No/Cgmp Signalling

Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells

Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis

Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β‐catenin signaling pathway

Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice

HIF-1 signalling pathway was identified as a potential new pathway for Icariin's treatment against Alzheimer's disease based on preclinical evidence and bioinformatics

Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacology

Icariin Improves the Cognitive Function of APP/PS1 Mice Via Suppressing Endoplasmic Reticulum Stress.